Orphan Drug Accelerator Cydan Expands Transactional Expertise With Appointment Of Vered Bisker-Leib, Ph.D., MBA, As Chief Business Officer

Cydan Development, Inc., an orphan drug accelerator that identifies and de-risks programs with significant therapeutic and commercial potential, today announced the appointment of Vered Bisker-Leib, Ph.D., MBA, as Chief Business Officer. Dr. Bisker-Leib brings a proven track record of identifying, evaluating and executing business development activities in top-tier companies, with expertise in licensing as well as mergers and acquisitions.

Help employers find you! Check out all the jobs and post your resume.